5 years ago
MRUS
AnalystsAndrew BerensAndrew Berens's Stock Forecasts
AnalystsAndrew Berens
Analyst Ranking
Bottom 3%
#5160 out of 5296 analysts
Average Return
-4.93%
Win Rate
39%64 out of 163
Risk vs Reward
Poor
Good
Andrew Berens's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Cogent Biosciences IncCOGT | +254.76% | $9.35 | $33.17 | 2025-07-06 - 2026-06-15 | Buy |
Forma Therapeutics Holdings IncFMTX | +246.79% | $5.77 | $20.01 | 2022-05-26 - 2022-10-13 | Buy |
Compass Therapeutics IncCMPX | +221.30% | $1.69 | $5.43 | 2025-04-01 - 2026-04-01 | Buy |
Turning Point Therapeutics IncTPTX | +191.29% | $25.50 | $74.28 | 2022-05-10 - 2022-06-13 | Buy |
Global Blood Therapeutics IncGBT | +167.43% | $24.90 | $66.59 | 2021-12-13 - 2022-08-09 | Buy |
Andrew Berens Analyst Color
Get additional color on Andrew Berens's coverage of popular stocks
Andrew Berens's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Tango Therapeutics IncTNGX | 3 | Buy | $69.00 | +109.73% | Maintains | 8 days ago |
Regeneron Pharmaceuticals IncREGN | 3 | Hold | $641.00 | +4.23% | Downgrades | a month ago |
Immunome IncIMNM | 1 | Buy | $33.00 | +82.62% | Maintains | a month ago |
Zymeworks IncZYME | 11 | Buy | $58.00 | +149.36% | Maintains | 3 months ago |
Relmada Therapeutics IncRLMD | 1 | Buy | $8.00 | +25.59% | Upgrades | 5 months ago |
Damora Therapeutics IncDMRA | 1 | Buy | $46.00 | +129.20% | Initiates Coverage On | 5 months ago |
Agios Pharmaceuticals IncAGIO | 11 | Buy | $40.00 | +25.71% | Maintains | 6 months ago |
Nuvalent IncNUVL | 3 | Buy | $149.00 | +20.79% | Maintains | 7 months ago |
Cogent Biosciences IncCOGT | 6 | Buy | $50.00 | +50.74% | Maintains | 7 months ago |
Immuneering CorpIMRX | 1 | Buy | $15.00 | +258.00% | Initiates Coverage On | 8 months ago |
Merus NvMRUS | 6 | Hold | $97.00 | +7.78% | Downgrades | 8 months ago |
Bridgebio Oncology Therapeutics IncBBOT | 1 | Buy | $25.00 | +223.42% | Initiates Coverage On | 9 months ago |
Celcuity IncCELC | 2 | Buy | $60.00 | -32.00% | Maintains | a year ago |
Arvinas IncARVN | 6 | Hold | $9.00 | N/A | Downgrades | a year ago |
Compass Therapeutics IncCMPX | 3 | Buy | $6.00 | N/A | Upgrades | a year ago |
Elevation Oncology IncELEV | 5 | Hold | $1.00 | N/A | Downgrades | a year ago |
Onkure Therapeutics IncOKUR | 1 | Buy | $33.00 | N/A | Initiates Coverage On | 2 years ago |
Gilead Sciences IncGILD | 1 | Buy | $96.00 | N/A | Upgrades | 2 years ago |
Viracta Therapeutics IncVIRX | 5 | Hold | $3.00 | N/A | Downgrades | 2 years ago |
Blueprint Medicines CorpBPMC | 17 | Hold | $97.00 | N/A | Upgrades | 2 years ago |
Incyte CorpINCY | 12 | Buy | $78.00 | N/A | Upgrades | 3 years ago |
Mirati Therapeutics IncMRTX | 7 | Hold | $58.00 | N/A | Downgrades | 3 years ago |
Cti Biopharma CorpCTIC | 2 | Hold | $9.10 | N/A | Downgrades | 3 years ago |
Deciphera Pharmaceuticals IncDCPH | 8 | Buy | $30.00 | N/A | Reiterates | 3 years ago |
Seagen IncSGEN | 19 | Hold | $141.00 | N/A | Downgrades | 3 years ago |
Beone Medicines LtdONC | 9 | Buy | $300.00 | N/A | Maintains | 3 years ago |
Nurix Therapeutics IncNRIX | 3 | Buy | $28.00 | N/A | Maintains | 4 years ago |
Astrazeneca PLCAZN | 10 | Buy | $79.00 | N/A | Maintains | 4 years ago |
Zentalis Pharmaceuticals IncZNTL | 7 | Buy | $27.00 | N/A | Maintains | 4 years ago |
Aveo Pharmaceuticals IncAVEO | 3 | Hold | N/A | N/A | Downgrades | 4 years ago |
Hookipa Pharma IncHOOK | 4 | Buy | $30.00 | N/A | Maintains | 4 years ago |
Global Blood Therapeutics IncGBT | 4 | Hold | $68.50 | N/A | Downgrades | 4 years ago |
Turning Point Therapeutics IncTPTX | 5 | Hold | $76.00 | N/A | Downgrades | 4 years ago |
Forma Therapeutics Holdings IncFMTX | 5 | Buy | $23.00 | N/A | Maintains | 4 years ago |
Cullinan Therapeutics IncCGEM | 3 | Buy | $25.00 | N/A | Maintains | 4 years ago |
Aura Biosciences IncAURA | 1 | Buy | $40.00 | N/A | Initiates Coverage On | 5 years ago |
Theseus Pharmaceuticals IncTHRX | 1 | Buy | $28.00 | N/A | Initiates Coverage On | 5 years ago |
C4 Therapeutics IncCCCC | 1 | Buy | $67.00 | N/A | Initiates Coverage On | 5 years ago |
Monte Rosa Therapeutics IncGLUE | 1 | Hold | $20.00 | N/A | Initiates Coverage On | 5 years ago |
Epizyme IncEPZM | 4 | Buy | $16.00 | N/A | Upgrades | 5 years ago |
Clovis Oncology IncCLVSQ | 2 | Sell | $5.00 | N/A | Downgrades | 6 years ago |
Nabriva Therapeutics PLCNBRVF | 2 | Strong Buy | $2,000.00 | N/A | Reinstates | 8 years ago |
Tesaro IncTSRO | 2 | Strong Buy | $146.00 | N/A | Maintains | 8 years ago |
Intercept Pharmaceuticals IncICPT | 1 | Strong Sell | $50.00 | N/A | Maintains | 9 years ago |
Ocular Therapeutix IncOCUL | 2 | Hold | $8.00 | N/A | Maintains | 9 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.